Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 28.23M
March 31, 2026 18.96M
December 31, 2025 0.731M
September 30, 2025 -12.71M
June 30, 2025 -6.036M
March 31, 2025 4.573M
December 31, 2024 14.56M
September 30, 2024 -0.955M
June 30, 2024 -4.048M
March 31, 2024 -17.23M
December 31, 2023 -33.08M
September 30, 2023 -28.86M
June 30, 2023 -44.01M
March 31, 2023 -42.01M
Date Value
December 31, 2022 -35.27M
September 30, 2022 -30.22M
June 30, 2022 -23.55M
March 31, 2022 -18.82M
December 31, 2021 -23.12M
September 30, 2021 -17.49M
June 30, 2021 -16.62M
March 31, 2021 -12.52M
December 31, 2020 -26.15M
September 30, 2020 -35.07M
June 30, 2020 -36.06M
March 31, 2020 -43.73M
December 31, 2019 -32.18M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
LataMed AI Corp. -0.2553M
SCWorx Corp. -0.7456M
GoodRx Holdings, Inc. 201.58M
Claritev Corp. 133.04M
iSpecimen, Inc. -7.004M